A new paradigm for the management of ATL

Graham P Taylor^{1

2}, Lucy B Cook^{1

2}

Affiliations

¹ Section of Virology, Department on Infectious Disease, Imperial College London, London, UK.
² National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, UK.

Graham P Taylor et al. Br J Haematol. 2022 Sep.

. 2022 Sep;198(6):941-942.

doi: 10.1111/bjh.18363. Epub 2022 Jul 15.

Graham P Taylor^{1

2}, Lucy B Cook^{1

2}

¹ Section of Virology, Department on Infectious Disease, Imperial College London, London, UK.
² National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, UK.

No abstract available

References

1. IARC monographs on the evaluation of carcinogenic risk to humans: human immunodeficiency viruses and human T‐cell lymphotropic viruses Lyon: IARC. 1996. Available from: http://monographs.iarc.fr/ENG/Monographs/vol67/index.php. - PMC - PubMed
1. Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126(24):2570–7. - PubMed
1. Ishida T, Iida S, Akatsuka Y, Ishii T, Miyazaki M, Komatsu H, et al. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T‐cell leukemia/lymphoma. Clin Cancer Res. 2004;10(22):7529–39. - PubMed
1. Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, et al. Defucosylated anti‐CCR4 monoclonal antibody (KW‐0761) for relapsed adult T‐cell leukemia‐lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30(8):837–42. - PubMed
1. Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K, et al. Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study. Br J Haematol. 2015;169(5):672–82. - PMC - PubMed